1887
  1. Home
  2. A-Z Publications
  3. Qatar Medical Journal
  4. Volume 2024, Issue 3
  5. Article
Volume 2024, Issue 3
  • ISSN: 0253-8253
  • EISSN: 2227-0426

Abstract

In a bold departure from conventional healthcare paradigms, Qatar’s Assisted Home Hemodialysis (AHHD) national program stands as a testament to Hamad Medical Corporation’s unwavering commitment to excellence. This innovative care model is tailored to address the distinct challenges of hemodialysis patients, particularly the elderly, who require ambulance transport. It provides them with the convenience of at-home dialysis with the full support of dedicated nursing care. AHHD included 76 patients from July 2021 to December 2022. It has significantly improved patients’ quality of life, achieving an exceptional 99% satisfaction rate with an extremely low complication rate. It has also delivered tangible improvements in health outcomes, marked by a reduction in hospitalizations, decreased transmission of COVID-19, cost-effectiveness, alleviating strain on ambulance services, and reducing demand for dialysis slots and manpower. In conclusion, the clinical and financial success of the AHHD program positions it as a superior alternative to traditional in-center dialysis, particularly in its capacity to cater to the needs of the most complex and challenging patient populations.

© 2024 Hamad, Abdelhai, Elsherbiny, Abdelwahed, Tolba, Chembolu, et al., Licensee HBKU Press.
Loading

Article metrics loading...

/content/journals/10.5339/qmj.2024.28
2024-08-06
2024-11-13
Loading full text...

Full text loading...

/deliver/fulltext/qmj/2024/3/qmj.2024.28.html?itemId=/content/journals/10.5339/qmj.2024.28&mimeType=html&fmt=ahah

References

  1. Garcia-Garcia G, Jha V, Tao Li PK, Garcia-Garcia G, Couser WG, Erk T, et al.. Chronic kidney disease (CKD) in disadvantaged populations. Clin Kidney J. 2015; 8:(1):3–6. doi: 10.1093/ckj/sfu124
     [Google Scholar]
  2. Finkelstein EA, Ozdemir S, Malhotra C, Jafar TH, Choong HL, Suhardjono J. Identifying factors that influence physicians’ recommendations for dialysis and conservative management in Indonesia. Kidney Int Rep. 2017; 2:(2):212–8. doi: 10.1016/j.ekir.2016.12.002
     [Google Scholar]
  3. Vadakedath S, Venkataramana K. Dialysis: A review of the mechanisms underlying complications in the management of chronic renal failure. Cureus. 2017; 9:(8):e1603. doi: 10.7759/cureus.1603
     [Google Scholar]
  4. Blagg CR. A brief history of home hemodialysis. Adv Ren Replace Ther. 1996; 3:(2):99–105. doi: 10.1016/s1073-4449(96)80048-3
     [Google Scholar]
  5. US Renal Data System. Section K.2: Healthcare expenditures for ESRD patients. In: 2019 USRDS annual data report: Epidemiology of kidney disease in the United States. Bethesda, MD; 2019. Available from: https://usrds-adr.niddk.nih.gov/2022/end-stage-renal-disease/9-healthcare-expenditures-for-persons-with-esrd. Accessed 3 Mar 2024.
     [Google Scholar]
  6. Howell M, Walker RC, Howard K. Cost effectiveness of dialysis modalities: A systematic review of economic evaluations. Appl Health Econ Health Policy. 2019; 17:(3):315–30. doi: 10.1007/s40258-018-00455-2
     [Google Scholar]
  7. Chui BK, Manns B, Pannu N, Dong J, Wiebe N, Jindal K, et al.. Health care costs of peritoneal dialysis technique failure and dialysis modality switching. Am J Kidney Dis. 2013; 61:104–11. doi: 10.1053/j.ajkd.2012.07.010
     [Google Scholar]
  8. Lee H, Manns B. Cost analysis of ongoing care of patients with end-stage renal disease: The impact of dialysis modality and dialysis access. Am J Kidney Dis. 2002; 40:611–22. doi: 10.1053/ajkd.2002.34924
     [Google Scholar]
  9. Ishani A, Slinin Y, Greer N, MacDonald R, Messana J, Rutks I, et al.. Comparative effectiveness of home-based kidney dialysis versus in-center or other outpatient kidney dialysis locations—A systematic review [Internet]. Washington, DC:Department of Veterans Affairs (US);2015.
    [Google Scholar]
  10. Nesrallah GE, Li L, Suri RS. Comparative effectiveness of home dialysis therapies: A matched cohort study. Can J Kidney Health Dis. 2016; 3:(1):105. doi: 10.1186/s40697-016-0105-x
     [Google Scholar]
  11. Rydell H, Ivarsson K, Almquist M, Segelmark M, Clyne N. Improved long-term survival with home hemodialysis compared with institutional hemodialysis and peritoneal dialysis: A matched cohort study. BMC Nephrol. 2019; 20:(1):52. doi: 10.1186/s12882-019-1245-x
     [Google Scholar]
  12. Mowatt G, Vale L, MacLeod A. Systematic review of the effectiveness of home versus hospital or satellite unit hemodialysis for people with end-stage renal failure. Int J Technol Assess Health Care. 2004Summer; 20:(3):258–68. doi: 10.1017/s0266462304001060
     [Google Scholar]
  13. Tran E, Karadjian O, Chan CT, Trinh E. Home hemodialysis technique survival: Insights and challenges. BMC Nephrol. 2023; 24:(1):205. doi: 10.1186/s12882-023-03264-5
     [Google Scholar]
  14. Ok E, Demirci C, Asci G, Yuksel K, Kircelli F, Koc SK, et al.. Turkish Home Hemodialysis Initiative. Patient survival with extended home hemodialysis compared to in-center conventional hemodialysis. Kidney Int Rep. 2023; 8:(12):2603–15. doi: 10.1016/j.ekir.2023.09.007
     [Google Scholar]
  15. Guerraoui A, Galland R, Belkahla-Delabruyere F, Didier O, Berger V, Sauvajon P, et al.. Design of therapeutic education workshops for home haemodialysis in a patient-centered chronic kidney diseases research: A qualitative study. BMC Nephrol. 2022; 23:53. doi: 10.1186/s12882-022-02683-0
     [Google Scholar]
  16. Chertow GM, Levin NW, Beck GJ, Depner TA, Eggers PW, Gassman JJ, et al.. FHN Trial Group. In-center hemodialysis six times per week versus three times per week. N Engl J Med. 2010; 363:(24):2287–300. doi: 10.1056/NEJMoa1001593. Epub 2010 Nov 20. Erratum in: N Engl J Med. 2011;364(1):93. doi: 10.1056/NEJMoa1001593
     [Google Scholar]
  17. Navva PKR, Venkata Sreepada S, Shivanand Nayak K. Present status of renal replacement therapy in Asian countries. Blood Purif. 2015; 40:(4):280–7. doi: 10.1159/000441574
     [Google Scholar]
  18. Wilkie M. Home dialysis—An international perspective. NDT Plus. 2011; 4:(Suppl. 3):iii4–6. doi: 10.1093/ndtplus/sfr129
     [Google Scholar]
  19. Young BA, Chan C, Blagg C, Lockridge R, Golper T, Finkelstein F, et al.. ASN Dialysis Advisory Group. How to overcome barriers and establish a successful home HD program. Clin J Am Soc Nephrol. 2012; 7:(12):2023–32. doi: 10.2215/CJN.07080712
     [Google Scholar]
  20. Ajaimy M, Melamed M. COVID-19 in patients with kidney disease. Clin J Am Soc Nephrol. 2020; 15:(8):1087–9. doi: 10.2215/CJN.09730620
     [Google Scholar]
  21. Quintaliani G, Reboldi G, Di Napoli A, Nordio M, Limido A, Aucella F, et al.. Italian Society of Nephrology COVID-19 Research Group. Exposure to novel coronavirus in patients on renal replacement therapy during the exponential phase of COVID-19 pandemic: Survey of the Italian Society of Nephrology. J Nephrol. 2020; 33:(4):725–36. doi: 10.1007/s40620-020-00794-1
     [Google Scholar]
  22. Brown EA, Perl J. Increasing peritoneal dialysis use in response to the COVID-19 pandemic: Will it go viral? J Am Soc Nephrol. 2020; 31:(9):1928–30. doi: 10.1681/ASN.2020050729
     [Google Scholar]
  23. US Renal Data System. USRDS 2020 annual data report COVID-19 supplement. https://adr.usrds.org/2020/covid-19-supplement/1-covid-19-supplement. Accessed 25 Feb 2021.
     [Google Scholar]
  24. Jager KJ, Korevaar JC, Dekker FW. Netherlands Cooperative Study on the Adequacy of Dialysis Study Group. The effect of contraindications and patient preference on dialysis modality selection in ESRD patients in The Netherlands. Am J Kidney Dis. 2004; 43:891–9. doi: 10.1053/j.ajkd.2003.12.051
     [Google Scholar]
  25. McLaughlin K, Manns B, Mortis G. Why patients with ESRD do not select self-care dialysis as a treatment option. Am J Kidney Dis. 2003; 41:380–5. doi: 10.1053/ajkd.2003.50047
     [Google Scholar]
  26. Stack A. Determinants of modality selection among incident US dialysis patients: Results from a national study. J Am Soc Nephrol. 2002; 13:1279–87. doi: 10.1681/ASN.V1351279
     [Google Scholar]
  27. Oliver MJ, Garg AX. Impact of contraindications, barriers to self-care and support on incident peritoneal dialysis utilization. Nephrol Dial Transplant. 2010; 25:2737–44. doi: 10.1093/ndt/gfq085
     [Google Scholar]
  28. Iyasere O, Brown E. Longitudinal trends in quality of life and physical function in frail older dialysis patients: A comparison of assisted peritoneal dialysis and in-center hemodialysis. Perit Dial Int. 2019; 39:112–8. doi: 10.3747/pdi.2018.00086
     [Google Scholar]
  29. Duquennoy S, Bechade C. Is peritonitis risk increased in elderly patients on peritoneal dialysis? Report from the French Language Peritoneal Dialysis Registry (RDPLF). Perit Dial Int. 2016; 36:291–6. doi: 10.3747/pdi.2014.00154
     [Google Scholar]
  30. Lanot A, Bechade C. Assisted peritoneal dialysis and transfer to haemodialysis: A cause-specific analysis with data from the RDPLF. Nephrol Dial Transplant. 2021; 36:330–9. doi: 10.1093/ndt/gfaa289
     [Google Scholar]
  31. Oliver MJ, Al-Jaishi AA. Hospitalization rates for patients on assisted peritoneal dialysis compared with in-center hemodialysis. Clin J Am Soc Nephrol. 2016; 11:1606–14. doi: 10.2215/CJN.10130915
     [Google Scholar]
  32. Reddy NC, Korbet SM, Wozniak JA. Staff-assisted nursing home haemodialysis: Patient characteristics and outcomes. Nephrol Dial Transplant. 2007; 22:1399–406. doi: 10.1093/ndt/gfl809
     [Google Scholar]
  33. Agraharkar M, Du Y, Ahuja T, Barclay C. Comparison of staff-assisted home hemodialysis with in-center hemodialysis and in-hospital hemodialysis. Hemodial Int. 2002; 6:58–62. doi: 10.1111/hdi.2002.6.1.58
     [Google Scholar]
  34. Hamad A, Mefleh Al Halabi A, Ghazouani H, Habas EM, Mohamed Borham A, Mohamed Ismail S, et al.. Time-series forecasting of hemodialysis population in the State of Qatar by 2030. Qatar Med J. 2023; 2023:(1):6. doi: 10.5339/qmj.2023.6
     [Google Scholar]
  35. Hamad AI, Asim M, Othman MA, Abuhelaiqa EA, Shurrab A, Elmadhoun IT, et al.. National response to the COVID-19 Omicron variant crisis in the ambulatory hemodialysis service in the State of Qatar. Qatar Med J. 2022; 2022:(3):38. doi: 10.5339/qmj.2022.38
     [Google Scholar]
  36. Asim M, Alkadi M, Hamad A, Othman M, Abuhelaiqa E, Fituri O, et al.. Restructuring nephrology services to combat COVID-19 pandemic: Report from a Middle Eastern country. World J Nephrol. 2020; 9:(2):9–17. doi: 10.5527/wjn.v9.i2.9
     [Google Scholar]
  37. Al Sahlawi M, AlRukhaimi M, Al-Ghamdi SM, Al Salmi I, Al-Aradi AH, Hamad A, et al.. Peritoneal dialysis in the Arabian Gulf countries: Challenges and opportunities. Perit Dial Int. 2024; 44:(3):171–6. doi: 10.1177/08968608231204107
     [Google Scholar]
/content/journals/10.5339/qmj.2024.28
Loading
Qatar’s assisted home hemodialysis program: A beacon of hope for the vulnerable patient
Qatar Medical Journal 2024, 28 (2024); https://doi.org/10.5339/qmj.2024.28
/content/journals/10.5339/qmj.2024.28
/content/journals/10.5339/qmj.2024.28
Loading

Data & Media loading...

  • Article Type: Research Article
Keyword(s): accessibility, Dialysis center, spatial, time and travel distance

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error